NIH #1I01CX002801-01A1
Biomarker Directed trial of Temozolomide and PARP inhibition in relapsed SCLC
Active
- Amount
- —
- Period
- 2025-07-01 → 2030-06-30
- PIs
- 2
Awarded at RLR VA MEDICAL CENTER
NIH #5U2CCA271885-04
Administrative Core
Active
- Amount
- $281K
- Period
- 2022-09-16 → 2027-08-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5U2CCA271885-03
Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies
Active
- Amount
- $847K
- Period
- 2022-09-16 → 2027-08-31
- PIs
- 3
- Est. capacity / PI
- ~1 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5U2CCA271885-02
Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies
Active
- Amount
- $880K
- Period
- 2022-09-16 → 2027-08-31
- PIs
- 3
- Est. capacity / PI
- ~1 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #1U2CCA271885-01
Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies
Active
- Amount
- $659K
- Period
- 2022-09-16 → 2027-08-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #4P30CA047904-37
Cancer Epidemiology and Prevention Program
Active
- Amount
- $39K
- Period
- 1997-09-10 → 2027-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5P30CA047904-36
Cancer Epidemiology and Prevention Program
- Amount
- $40K
- Period
- 1997-09-10 → 2025-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5P30CA047904-35
Cancer Epidemiology and Prevention Program
- Amount
- $40K
- Period
- 1997-09-10 → 2025-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5P30CA047904-34
Cancer Epidemiology and Prevention Program
- Amount
- $40K
- Period
- 1997-09-10 → 2025-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5P30CA047904-33
Cancer Epidemiology and Prevention Program
- Amount
- $36K
- Period
- 1997-09-10 → 2025-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #2P30CA047904-32
Cancer Epidemiology and Prevention Program
- Amount
- $39K
- Period
- 1997-09-10 → 2025-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #3U01CA214165-05S1
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung Cancer
- Amount
- $234K
- Period
- 2016-09-15 → 2023-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5U01CA214165-05
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung Cancer
- Amount
- $572K
- Period
- 2016-09-15 → 2023-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5U01CA214165-04
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung Cancer
- Amount
- $559K
- Period
- 2016-09-15 → 2021-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5U01CA214165-03
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung Cancer
- Amount
- $580K
- Period
- 2016-09-15 → 2021-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5U01CA214165-02
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung Cancer
- Amount
- $581K
- Period
- 2016-09-15 → 2021-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #1U01CA214165-01
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung Cancer
- Amount
- $595K
- Period
- 2016-09-15 → 2021-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5P50CA090440-15
SPORE in Lung Cancer
- Amount
- $2.2M
- Period
- 2001-06-01 → 2017-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5P50CA090440-14
SPORE in Lung Cancer
- Amount
- $2.2M
- Period
- 2001-06-01 → 2016-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5P50CA058184-18
P1: Epigenetic Staging and Therapy for Lung Cancers
- Amount
- $320K
- Period
- — → 2015-11-30
- PIs
- 1
- Est. capacity / PI
- ~5 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #2P50CA058184-14A1
P1: Epigenetic Staging and Therapy for Lung Cancers
- Amount
- $427K
- Period
- 2008-10-01 → 2013-09-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5R33CA127055-05
CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer
- Amount
- $262K
- Period
- 2008-08-01 → 2013-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5R33CA127055-04
CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer
- Amount
- $271K
- Period
- 2008-08-01 → 2012-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5R33CA127055-03
CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer
- Amount
- $271K
- Period
- 2008-08-01 → 2012-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #4R33CA127055-02
CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer
- Amount
- $271K
- Period
- 2008-08-01 → 2012-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #1R21CA127055-01
CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer
- Amount
- $230K
- Period
- 2007-07-01 → 2009-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P30CA047904-31
Lung Cancer Program (Project-009)
- Amount
- $35K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5P50CA058184-17
P1: Epigenetic Staging and Therapy for Lung Cancers
- Amount
- $342K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~5 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P50CA058184-16
P1: Epigenetic Staging and Therapy for Lung Cancers
- Amount
- $299K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~4 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P50CA058184-15
P1: Epigenetic Staging and Therapy for Lung Cancers
- Amount
- $280K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~4 students
Awarded at JOHNS HOPKINS UNIVERSITY